Zynex(ZYXI)
搜索文档
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zynex, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZYXI
GlobeNewswire News Room· 2025-04-24 00:27
诉讼案件概述 - 罗森律师事务所提醒在2023年3月13日至2025年3月11日期间购买Zynex公司(NASDAQ: ZYXI)证券的投资者注意2025年5月19日的首席原告截止日期 [1] - 投资者可能有权通过风险代理安排获得赔偿而无需支付任何自付费用 [1] 诉讼案件细节 - 指控Zynex公司在整个诉讼期间未能向投资者披露以下信息: - 公司过量发货产品包括电极 [4] - 这一做法导致公司虚增收入 [4] - 公司提交虚假索赔的做法引起了包括Tricare在内的保险公司的审查 [4] - 公司可能面临从保险公司网络中移除和联邦政府处罚等不利后果 [4] - 公司管理层关于业务、运营和前景的积极陈述存在重大误导或缺乏合理依据 [4] 律师事务所背景 - 罗森律师事务所专注于证券集体诉讼和股东衍生诉讼 [3] - 该所曾创下针对中国公司的最大证券集体诉讼和解记录 [3] - 2017年被ISS证券集体诉讼服务评为证券集体诉讼和解数量第一 [3] - 自2013年以来每年排名前四 [3] - 2019年为投资者追回超过4.38亿美元 [3] - 2020年创始合伙人Laurence Rosen被law360评为原告律师界泰斗 [3] 参与诉讼方式 - 投资者可通过指定网址、电话或邮箱联系Phillip Kim律师参与集体诉讼 [2][5] - 首席原告需在2025年5月19日前向法院提出申请 [2] - 首席原告是代表其他集体成员指导诉讼的代表方 [2]
Zynex Sets First Quarter 2025 Earnings Call
Prnewswire· 2025-04-22 21:15
ENGLEWOOD, Colo., April 22, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Tuesday, April 29, 2025 at 4:15 PM Eastern Time to discuss its financial results for the first quarter ended March 31, 2025. Financial results will be issued in a press release prior to the call.Zynex management will host the co ...
Levi & Korsinsky Notifies Zynex, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ZYXI
Prnewswire· 2025-04-22 17:45
NEW YORK, April 22, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Zynex, Inc. ("Zynex, Inc." or the "Company") (NASDAQ: ZYXI) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Zynex, Inc. investors who were adversely affected by alleged securities fraud between March 13, 2023 and March 11, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/zynex-inc-lawsuit-submission-fo ...
Lost Money on Zynex, Inc.(ZYXI)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
GlobeNewswire News Room· 2025-04-22 01:02
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Zynex, Inc. ("Zynex, Inc." or the "Company") (NASDAQ: ZYXI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Zynex, Inc. investors who were adversely affected by alleged securities fraud between March 13, 2023 and March 11, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/zynex-inc-lawsuit-submiss ...
Class Action Filed Against Zynex, Inc. (ZYXI) - May 19, 2025 Deadline to Join - Contact The Gross Law Firm
Prnewswire· 2025-04-21 17:45
NEW YORK, April 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI).Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=143826&from=4CLASS PERIOD: March 13, 2023 to March 11, 20 ...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Zynex, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZYXI
GlobeNewswire News Room· 2025-04-20 23:10
NEW YORK, April 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zynex, Inc. (NASDAQ: ZYXI) between March 13, 2023 and March 11, 2025, both dates inclusive (the “Class Period”), of the important May 19, 2025 lead plaintiff deadline. SO WHAT: If you purchased Zynex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NE ...
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Zynex, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZYXI
GlobeNewswire News Room· 2025-04-18 08:47
NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zynex, Inc. (NASDAQ: ZYXI) between March 13, 2023 and March 11, 2025, both dates inclusive (the “Class Period”), of the important May 19, 2025 lead plaintiff deadline. SO WHAT: If you purchased Zynex securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NE ...
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zynex
Prnewswire· 2025-04-18 00:18
公司诉讼调查 - 律师事务所Faruqi & Faruqi正在调查Zynex公司潜在的证券欺诈行为 并提醒投资者在2025年5月19日前申请成为集体诉讼的首席原告[2] - 诉讼指控Zynex及其高管违反联邦证券法 包括发布虚假/误导性声明 未披露超额发货产品及虚增收入等行为[4] - 公司被指控通过过量供应电极等耗材来提高账单金额 导致多家保险公司将其移出网络[5] 财务影响 - 2024年6月4日STAT医疗期刊报道公司"过量供应"行为后 股价单日下跌5%至9.35美元[5] - 2025年3月11日公布2024年Q4财报显示收入"短缺" 因Tricare等保险公司暂停付款审查历史账单 次日股价暴跌51.3%至3.41美元[6][7] 法律程序 - 法院将指定财务利益最大的投资者作为首席原告 代表集体诉讼成员监督诉讼进程[8] - 律师事务所呼吁知情人士提供Zynex行为的相关信息 包括举报人、前员工和股东等[9]
The Gross Law Firm Notifies Zynex, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ZYXI
Prnewswire· 2025-04-17 17:45
NEW YORK, April 17, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI).Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=143342&from=4 CLASS PERIOD: March 13, 2023 to March 11, 2 ...
RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms – Hagens Berman
GlobeNewswire News Room· 2025-04-17 05:32
SAN FRANCISCO, April 16, 2025 (GLOBE NEWSWIRE) -- Zynex, Inc. (NASDAQ: ZYXI), the Denver-based medical technology firm, is facing a deepening vortex of financial, regulatory and legal challenges, with RBC Capital Markets reportedly further reducing its outlook on the company’s stock. The company faces added pressure from a recently filed securities class action lawsuit, alleging the company made false and misleading statements regarding its revenue recognition practices and its relationship with Tricare, a ...